Evidence map›Paper›PMID 29318218›Full record

ArticleKidney international reports2017

Potential Benefit Associated With Delaying Initiation of Hemodialysis in a Japanese Cohort.

Satoshi Higuchi, Izaya Nakaya, Kazuhiro Yoshikawa, Yoichiro Chikamatsu, Ken-Ei Sada, Suguru Yamamoto, Satoko Takahashi, Hiroyo Sasaki, Jun Soma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Satoshi HiguchiDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Izaya NakayaDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Kazuhiro YoshikawaDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Yoichiro ChikamatsuDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Ken-Ei SadaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Suguru YamamotoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Satoko TakahashiDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Hiroyo SasakiDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Jun SomaDepartment of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan.
Iwate Prefectural Central Hospital · JPNiigata University · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLate referral to a nephrologist, the type of vascular access, nutritional status, and the estimated glomerular filtration rate (eGFR) at the start of hemodialysis (HD) have been reported as independent risk factors of survival for patients who begin HD. The aim of this study was to clarify the influence of the HD-free interval from the time of an eGFR of 10 ml/min per 1.73 m

methodsWe enrolled 124 patients aged older than 20 years who had HD initiated in a general hospital. The predictive factor was the HD-free I

resultsThe median I DISCUSSION: A longer HD-free I

Indexed as

all-cause mortalitycardiovascular eventestimated glomerular filtration ratehemodialysis-free intervalnephrology careperformance status

Identifiers

PMID29318218
PMCPMC5720530
OpenAlexW2586753231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.